Effect of ketanserin, a new blocking agent of the 5-HT2receptor, on airway responsiveness in asthma
- 1 February 1990
- Vol. 45 (2) , 151-153
- https://doi.org/10.1111/j.1398-9995.1990.tb00473.x
Abstract
Most of the antihypertensive drugs have a liability for adverse effects in asthma. Since there a few available data on the effect of ketanserin, a new antihypertensive drug which is a type-2 serotonin receptor antagonist, on human respiratory function, we have tested whether this drug can modify bronchial hyperresponsiveness to methacholine in asthmatic patients. The protective effect of intravenous ketanserin (0.14 mg/kg) was small, but significant.Keywords
This publication has 6 references indexed in Scilit:
- Captopril-induced CoughChest, 1988
- Ketanserin, A New Blocking Agent of Serotonin S2-ReceptorsChest, 1987
- Captopril-related (and -induced?) AsthmaAmerican Review of Respiratory Disease, 1987
- Management of Hypertension in the Asthmatic PatientChest, 1983
- Ketanserin in essential hypertension: Effects during rest and exerciseEuropean Journal of Clinical Pharmacology, 1983
- Bronchial asthma due to alpha-methyldopa.BMJ, 1979